The estimated Net Worth of Michael J. Bonello is at least $22.1 million dollars as of 17 June 2021. Mr. Bonello owns over 52,551 units of PRA Health Sciences Inc stock worth over $10,642,002 and over the last 5 years he sold PRAH stock worth over $9,351,996. In addition, he makes $2,137,000 as Chief Financial Officer et Executive Vice President at PRA Health Sciences Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Bonello PRAH stock SEC Form 4 insiders trading
Michael has made over 7 trades of the PRA Health Sciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 52,551 units of PRAH stock worth $4,593,483 on 17 June 2021.
The largest trade he's ever made was exercising 52,551 units of PRA Health Sciences Inc stock on 17 June 2021 worth over $4,593,483. On average, Michael trades about 12,018 units every 35 days since 2019. As of 17 June 2021 he still owns at least 64,415 units of PRA Health Sciences Inc stock.
You can see the complete history of Mr. Bonello stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Bonello biography
Michael J. Bonello serves as Chief Financial Officer, Executive Vice President of the Company. Mr. Bonello previously served as Senior Vice President, Accounting and Corporate Controller for the Company, after having joined the Company in 2008. Prior to joining the Company, Mr. Bonello held positions with Cree, Inc., where he was Director of Finance/Corporate Controller, and Genworth Financial (formerly GE Mortgage Insurance Corporation) where he served as Vice President, Domestic Controller and Global Reporting Leader. Mr. Bonello also served for seven years in the audit practice at PricewaterhouseCoopers, LLP. He received a BBA with a concentration in accounting from St. Bonaventure University.
What is the salary of Michael Bonello?
As the Chief Financial Officer et Executive Vice President of PRA Health Sciences Inc, the total compensation of Michael Bonello at PRA Health Sciences Inc is $2,137,000. There are 1 executives at PRA Health Sciences Inc getting paid more, with Colin Shannon having the highest compensation of $7,160,220.
How old is Michael Bonello?
Michael Bonello is 50, he's been the Chief Financial Officer et Executive Vice President of PRA Health Sciences Inc since 2018. There are 7 older and 2 younger executives at PRA Health Sciences Inc. The oldest executive at PRA Health Sciences Inc is Jeffrey Barber, 67, who is the Independent Director.
What's Michael Bonello's mailing address?
Michael's mailing address filed with the SEC is C/O SYNEOS HEALTH, INC., 1030 SYNC ST, MORRISVILLE, NC, 27560.
Insiders trading at PRA Health Sciences Inc
Over the last 10 years, insiders at PRA Health Sciences Inc have traded over $5,843,308,181 worth of PRA Health Sciences Inc stock. The most active insiders traders include Fund Holdings L.P.Kkr Fund ..., Fund Holdings L.P.Kkr Fund ... et Pra Investors L.P.Kkr Pra I.... On average, PRA Health Sciences Inc executives and independent directors trade stock every 39 days with the average trade being worth of $280,602,577. The most recent stock trade was executed by Christopher L Gaenzle on 17 June 2021, trading 27,497 units of PRAH stock currently worth $2,773,897.
What does PRA Health Sciences Inc do?
PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.
What does PRA Health Sciences Inc's logo look like?
Complete history of Mr. Bonello stock trades at PRA Health Sciences Inc et Syneos Health Inc
PRA Health Sciences Inc executives and stock owners
PRA Health Sciences Inc executives and other stock owners filed with the SEC include:
-
Colin Shannon,
Chairman of the Board, President, Chief Executive Officer -
Michael Bonello,
Chief Financial Officer, Executive Vice President -
Colin Shannon,
Chairman, CEO & Pres -
Linda Grais,
Independent Director -
Jeffrey Barber,
Independent Director -
Matthew Young,
Independent Director -
Alexander Dickinson,
Independent Director -
James Momtazee,
Lead Independent Director -
Glen Stettin,
Independent Director -
Christopher Gaenzle,
Executive Vice President, Chief Administrative Officer, General Counsel -
Dr. Michael Kirchengast,
Sr. VP of Scientific Affairs -
Patrick R. Spine,
VP of HR -
Tami Klerr-Naivar,
Exec. VP and Chief Sales & Marketing Officer -
Laurie Hurst,
Sr. Director of Communications & PR -
Thomas Byrne,
VP of Legal Affairs -
Kent Thoelke,
Exec. VP & Chief Scientific Officer -
Margaret Keegan,
Exec. VP & COO -
Pra Investors L.P.Kkr Pra I...,
-
Fund Holdings L.P.Kkr Fund ...,
-
Fund Holdings L.P.Kkr Fund ...,
-
David W Dockhorn,
Executive VP & CCO -
Linda Baddour,
Executive VP & CFO -
Pra Investors L.P.Kkr Pra I...,
-
Group Ltd Kkr Group Holding...,
-
Fund Holdings L.P.Kkr Fund ...,